APGE Cash & Short-Term Investments

Apogee Therapeutics Inc · Cash & Short-Term Investments

APGE logo

APGE Cash & Short-Term Investments

Latest reported$730.19M
APGE FY Cash & Short-Term Investments ($151.89M → $730.19M)
High-resolution chart · PNG

APGE cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Apogee Therapeutics Inc Cash & Short-Term Investments — Annual fiscal periods (USD)
Period endingCash & Short-Term Investments (USD)
730,192,000
520,653,000
395,459,000
151,890,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.